The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSoftcat Regulatory News (SCT)

Share Price Information for Softcat (SCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,610.00
Bid: 1,612.00
Ask: 1,614.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.124%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,610.00
SCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2023 Board Succession Planning

12 Jul 2022 07:00

RNS Number : 0813S
Softcat PLC
12 July 2022
 

12 July 2022

 

 

Softcat plc

 

2023 Board Succession Planning

 

 

The Board of Softcat plc ("Softcat", or the "Company"), a leading UK provider of IT infrastructure technology and services, is pleased to outline a series of steps it intends to take to ensure continued, effective leadership of the Company and orderly succession over the medium term. Whilst none of these steps take effect until 2023, the Board is sharing details of its plans in order to provide full transparency to shareholders.

 

 

2023 Planned Succession Steps

 

With effect from 1 August 2023, Graham Charlton will become CEO of Softcat. This follows eight years as CFO during which time Graham has developed a deep understanding of the business and what makes the Company successful, not least the Softcat culture, which he has championed since joining the Company. The Board believes Graham is the right person to lead the business successfully through the next stage of its growth.

 

A search for a CFO to succeed Graham Charlton has commenced and will consider external as well as internal candidates.

 

Also effective 1 August 2023, Graeme Watt will succeed Martin Hellawell as Non-Executive Chair. At the time of succession, Graeme will have been CEO of the business for over five years. This move has been carefully considered by the Board, which acknowledges that the appointment of the CEO into the role of the Chair is not in line with the recommendations of the UK Corporate Governance Code. However, the Board was unanimous that Graeme's deep knowledge of the business, Softcat's culture and its markets made him the ideal candidate to support the interests of all our stakeholders.

 

Both Graham and Graeme's appointments have been considered as part of the Board's succession planning process. External expertise from a leading independent executive and board search firm has also been used to consider the appropriateness and readiness of the candidates as well as alternatives.

 

With effect from 1 August 2023, Martin Hellawell, currently Non-Executive Chair of the Company will step down from his position and from the Softcat Board.

 

Outlining the planned steps, Karen Slatford, Chair of the Nomination Committee and Senior Independent Director said: "Softcat is a very special business with a distinct culture which puts people at the heart of everything we do. As we have been working on succession planning, we have been very focussed on ensuring that we protect and develop that culture and continue to be committed to the simple, proven growth strategy which has served us so well. Graeme and Graham are the best people to lead the Company and we all look forward to working with them when they assume their new roles in August 2023. We will miss Martin when he steps down as Chair but are confident that he leaves us with strong foundations for continued future success."

 

Graeme Watt commented "I am very excited to see Graham take the opportunity to lead the Company from next year. Graham has an intimate knowledge of Softcat which he has built up over eight years and I am confident he will continue to drive the business forward. I relish the opportunity to remain on the Board as Chair and believe we have established a very clear and successful governance model in this respect. That said, these changes are a year away. I will remain fully engaged and committed in my position as CEO and continue to drive the business hard for the next twelve months. On behalf of the Board and the Company I would like to pay tribute to Martin Hellawell for his outstanding contribution to Softcat over many years."

 

Finally, Martin Hellawell commented "It has been a privilege and a tremendous experience to have been involved with the Softcat team. When the time comes, I am very pleased to be leaving Softcat in the hands of extraordinary successors who I have every confidence will take the business to ever greater heights."

 

 

 

For further information, please contact:

 

Softcat plc

 

Graeme Watt, Chief Executive Officer

+44 (0)1628 403 610

Graham Charlton, Chief Financial Officer

Media Enquiries FTI Consulting LLP

 

Ed Bridges/Matt Dixon

+44 (0)20 3727 1000

 

 

This announcement has been determined to contain inside information.

 

 

Remuneration:

All remuneration terms and payments will be in line with the Directors' Remuneration Policy. The Remuneration Committee confirmed that Graeme Watt will be treated as a good leaver under the terms of the Directors' Remuneration Policy and associated plan rules. Further details on the specific remuneration payments will be included in the Directors' Remuneration Report in Softcat's 2022 Annual Report.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUAUNRUBUBAAR
Date   Source Headline
1st May 202410:50 amRNSTotal Voting Rights
9th Apr 20249:45 amRNSDirector/PDMR Shareholding
2nd Apr 20249:13 amRNSTotal Voting Rights
26th Mar 20241:00 pmRNSHolding(s) in Company
26th Mar 20247:00 amRNSHalf-year Report
15th Mar 20242:45 pmRNSDirector/PDMR Shareholding
4th Mar 20247:00 amRNSNotice of Results
1st Mar 20242:28 pmRNSHolding(s) in Company
1st Mar 202410:47 amRNSTotal Voting Rights
8th Feb 20249:34 amRNSDirector/PDMR Shareholding
1st Feb 20249:49 amRNSTotal Voting Rights
30th Jan 20249:58 amRNSHolding(s) in Company
9th Jan 20243:48 pmRNSDirector/PDMR Shareholding
9th Jan 202412:42 pmRNSHolding(s) in Company
2nd Jan 20249:50 amRNSTotal Voting Rights
18th Dec 20239:58 amRNSBlock listing Interim Review
14th Dec 202311:29 amRNSDirector/PDMR Shareholding
14th Dec 202311:25 amRNSResult of AGM
12th Dec 20234:20 pmRNSDirector/PDMR Shareholding
8th Dec 20231:02 pmRNSDirector/PDMR Shareholding
1st Dec 20233:58 pmRNSTotal Voting Rights
28th Nov 20237:00 amRNSQ1 2024 Trading Update
24th Nov 20234:54 pmRNSDirector/PDMR Shareholding
24th Nov 20234:51 pmRNSDirector/PDMR Shareholding
8th Nov 20233:22 pmRNSDirector/PDMR Shareholding
1st Nov 202310:08 amRNSAnnual Financial Report and Notice of AGM
24th Oct 20237:00 amRNSFinal Results
10th Oct 202310:40 amRNSDirector/PDMR Shareholding
4th Oct 20237:00 amRNSNotice of Results
2nd Oct 202310:38 amRNSTotal Voting Rights
8th Sep 20232:32 pmRNSDirector/PDMR Shareholding
1st Sep 202310:04 amRNSTotal Voting Rights
10th Aug 202310:59 amRNSDirector/PDMR Shareholding
1st Aug 202312:22 pmRNSTotal Voting Rights
1st Aug 20237:00 amRNSAppointment of Non-Executive Directors
10th Jul 20232:10 pmRNSDirector/PDMR Shareholding
3rd Jul 20239:19 amRNSTotal Voting Rights
8th Jun 202311:23 amRNSDirector/PDMR Shareholding
1st Jun 202312:32 pmRNSTotal Voting Rights
1st Jun 202311:08 amRNSBlock listing Interim Review
30th May 20237:00 amRNSQ3 2023 Trading Update
25th May 20238:47 amRNSDirector Declaration
10th May 20238:59 amRNSDirector/PDMR Shareholding
2nd May 20235:08 pmRNSTotal Voting Rights
12th Apr 202310:14 amRNSDirector/PDMR Shareholding
3rd Apr 20239:34 amRNSTotal Voting Rights
28th Mar 20237:00 amRNSHalf-year Report
16th Mar 20232:39 pmRNSConfirmation of CFO Appointment Date
15th Mar 20237:00 amRNSNotice of Results
9th Mar 20232:27 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.